Valneva initiates Phase 1/2 study of its vaccine candidate

Valneva initiates Phase 1/2 study of its vaccine candidate

2020-12-17 11:40:09 Valneva SE has announced the initiation of a Phase 1/2 clinical study for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. VLA2001 leverages the manufacturing platform of Valneva’s licensed Japanese encephalitis vaccine, IXIARO and...
Orion invests EUR 17 million in its production plants in Turku

Orion invests EUR 17 million in its production plants in Turku

2020-12-11 05:46:58 Orion upgrades the operations of its pharmaceutical plant in Turku by investing in a new cancer drug packaging line and by expanding its cream production department. The company is also building a new pure water system and district heating centre...

Pin It on Pinterest